Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients-Reference-Cited by-同舟云学术

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients

Published:2005-09 Issue:5 Volume:96 Page:415-422
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Geisler Jürgen,Haynes Ben,Anker Gun,Helle Hildegunn,Ekse Dagfinn,Dowsett Mitch,Lønning Per Eystein

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference46 articles.

1. Review of studies on estrogen biosynthesis in the human;Siiteri;Cancer Res.,1982

2. Estrogens and breast cancer;Siiteri;Ann. NY Acad. Sci.,1986

3. Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia;MacDonald;Obstet. Gynecol.,1976

4. Effects of suppression of estrogen action by the P450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys;Wickman;J. Clin. Endocrinol. Metab.,2003

5. Clinical review 144—estrogen and the male skeleton;Khosla;J. Clin. Endocrinol. Metab.,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models;Toxicology;2023-02

2. Theoretical study of encapsulation of diethylstilbestrol drug into the inner surface of BNNT toward designing a new nanocarrier for drug delivery systems;Materials Research Express;2022-04-01

3. Endocrine Disruptors Driven Female Reproductive Ailments;Proceedings of the Zoological Society;2021-11-20

4. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification;Nature Reviews Endocrinology;2019-11-12

5. GEPSI: A Gene Expression Profile Similarity-Based Identification Method of Bioactive Components in Traditional Chinese Medicine Formula;Evidence-Based Complementary and Alternative Medicine;2018